Cost–benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes–zoster epidemiology
- 9 May 2005
- Vol. 23 (25) , 3349-3355
- https://doi.org/10.1016/j.vaccine.2003.10.042
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Economic Evaluation of Vaccination Programs: The Impact of Herd-ImmunityMedical Decision Making, 2003
- Economic Evaluations of Varicella Vaccination ProgrammesPharmacoEconomics, 2003
- Contacts with varicella or with children and protection against herpes zoster in adults: a case-control studyThe Lancet, 2002
- Do the Benefits of Varicella Vaccination Outweigh the Long‐Term Risks? A Decision‐Analytic Model for Policymakers and PediatriciansClinical Infectious Diseases, 2002
- American Grandparents Providing Extensive Child Care to Their GrandchildrenThe Gerontologist, 2001
- Costs And Benefits Of Routine Varicella Vaccination In German ChildrenThe Journal of Infectious Diseases, 1996
- The incidence of herpes zosterArchives of internal medicine (1960), 1995
- Childhood vaccination against chickenpox: An analysis of benefits and costsThe Journal of Pediatrics, 1994
- Cost-effectiveness of a routine varicella vaccination program for US childrenPublished by American Medical Association (AMA) ,1994
- An Economic Evaluation of Varicella Vaccine for Pediatric Liver and Kidney Transplant RecipientsClinical Infectious Diseases, 1993